467 related articles for article (PubMed ID: 28423662)
1. Comparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma.
Cerasuolo A; Annunziata C; Tortora M; Starita N; Stellato G; Greggi S; Maglione MG; Ionna F; Losito S; Botti G; Buonaguro L; Buonaguro FM; Tornesello ML
Oncotarget; 2017 May; 8(21):34070-34081. PubMed ID: 28423662
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
Holzinger D; Wichmann G; Baboci L; Michel A; Höfler D; Wiesenfarth M; Schroeder L; Boscolo-Rizzo P; Herold-Mende C; Dyckhoff G; Boehm A; Del Mistro A; Bosch FX; Dietz A; Pawlita M; Waterboer T
Int J Cancer; 2017 Jun; 140(12):2748-2757. PubMed ID: 28316084
[TBL] [Abstract][Full Text] [Related]
3. [The role of human papillomavirus 16 early genes E2 and E6 and heterogeneous nuclear ribonucleoprotein E2 in cervical carcinogenesis and their interaction effect].
Gao W; Ding L; Song ZC; Feng MJ; Liu CL; Li XX; Song L; Lyu YJ; Wang JT
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Jan; 54(1):92-98. PubMed ID: 31914575
[No Abstract] [Full Text] [Related]
4. Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells.
Rampias T; Boutati E; Pectasides E; Sasaki C; Kountourakis P; Weinberger P; Psyrri A
Mol Cancer Res; 2010 Mar; 8(3):433-43. PubMed ID: 20215420
[TBL] [Abstract][Full Text] [Related]
5. Molecular variants of human papilloma virus 16 E2, E4, E5, E6 and E7 genes associated with cervical neoplasia in Romanian patients.
Plesa A; Anton G; Iancu IV; Diaconu CC; Huica I; Stanescu AD; Socolov D; Nistor E; Popa E; Stoian M; Botezatu A
Arch Virol; 2014 Dec; 159(12):3305-20. PubMed ID: 25143263
[TBL] [Abstract][Full Text] [Related]
6. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions.
Cricca M; Morselli-Labate AM; Venturoli S; Ambretti S; Gentilomi GA; Gallinella G; Costa S; Musiani M; Zerbini M
Gynecol Oncol; 2007 Sep; 106(3):549-57. PubMed ID: 17568661
[TBL] [Abstract][Full Text] [Related]
7. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells.
Jiang B; Xue M
Genet Mol Res; 2015 Sep; 14(3):10473-81. PubMed ID: 26400278
[TBL] [Abstract][Full Text] [Related]
8. HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study.
Economopoulou P; Koutsodontis G; Avgeris M; Strati A; Kroupis C; Pateras I; Kirodimos E; Giotakis E; Kotsantis I; Maragoudakis P; Gorgoulis V; Scorilas A; Lianidou E; Psyrri A
PLoS One; 2019; 14(5):e0215984. PubMed ID: 31071126
[TBL] [Abstract][Full Text] [Related]
9. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
[TBL] [Abstract][Full Text] [Related]
10. mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model.
Callejas-Valera JL; Iglesias-Bartolome R; Amornphimoltham P; Palacios-Garcia J; Martin D; Califano JA; Molinolo AA; Gutkind JS
Carcinogenesis; 2016 Oct; 37(10):1014-25. PubMed ID: 27538837
[TBL] [Abstract][Full Text] [Related]
11. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
Rampias T; Sasaki C; Weinberger P; Psyrri A
J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
[TBL] [Abstract][Full Text] [Related]
12. Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma.
Halec G; Holzinger D; Schmitt M; Flechtenmacher C; Dyckhoff G; Lloveras B; Höfler D; Bosch FX; Pawlita M
Br J Cancer; 2013 Jul; 109(1):172-83. PubMed ID: 23778529
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis.
Laborde RR; Janus JR; Olsen SM; Wang VW; Garcia JJ; Graham RP; Moore EJ; Olsen KD; Kasperbauer JL; Price DL; Berres M; Halling G; Smith DI
Laryngoscope; 2012 Dec; 122(12):2707-11. PubMed ID: 22961429
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic characterization of p53 mutated oropharyngeal squamous cell carcinoma cells transformed with human papillomavirus E6 and E7 oncogenes.
Oh JE; Kim JO; Shin JY; Zhang XH; Won HS; Chun SH; Jung CK; Park WS; Nam SW; Eun JW; Kang JH
Int J Oncol; 2013 Aug; 43(2):383-93. PubMed ID: 23708675
[TBL] [Abstract][Full Text] [Related]
15. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
16. E2/E6 ratio and L1 immunoreactivity as biomarkers to determine HPV16-positive high-grade squamous intraepithelial lesions (CIN2 and 3) and cervical squamous cell carcinoma.
Choi YJ; Lee A; Kim TJ; Jin HT; Seo YB; Park JS; Lee SJ
J Gynecol Oncol; 2018 May; 29(3):e38. PubMed ID: 29400024
[TBL] [Abstract][Full Text] [Related]
17. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
18. HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas.
Kreimer AR; Clifford GM; Snijders PJ; Castellsagué X; Meijer CJ; Pawlita M; Viscidi R; Herrero R; Franceschi S;
Int J Cancer; 2005 Jun; 115(2):329-32. PubMed ID: 15688391
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
[TBL] [Abstract][Full Text] [Related]
20. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
